Research Article
CD30 Is Highly Expressed in Chronic Obstructive Pulmonary Disease and Induces the Pulmonary Vascular Remodeling
Table 1
Clinical data of participants.
| Index | Groups | value | AECOPD | Stable COPD |
| Age | 75.00 ± 7.60 | 70.05 ± 8.84 | 0.006 | Heart rate (minute) | 92.00 ± 15.38 | 78.12 ± 12.49 | <0.0001 | Smoke (packs.year) | 57.00 ± 109.29 | 16.55 ± 22.86 | 0.021 | Oxygen saturation (%) | 94.02 ± 7.01 | 92.88 ± 9.23 | 0.516 | PaO2 (mmHg) | 82.62 ± 22.73 | 82.69 ± 23.62 | 0.989 | PaCO2 (mmHg) | 50.23 ± 14.63 | 40.74 ± 7.67 | <0.0001 | PaO2/FiO2 (mmHg) | 320.24 ± 109.63 | 366.74 ± 139.91 | 0.087 | FEV1 (L) | 0.77 ± 0.41 | 1.37 ± 0.50 | <0.0001 | FEV1/FVC (%) | 44.90 ± 13.02 | 58.20 ± 10.45 | <0.0001 | LVEF (%) | 64.98 ± 8.61 | 62.50 ± 16.83 | 0.389 | PASP (mmHg) | 34.11 ± 14.26 | 26.21 ± 9.19 | 0.003 | FiO2 (%) | 27.29 ± 7.12 | 25.81 ± 11.51 | 0.470 | FEV1% (%) | 36.12 ± 13.69 | 58.12 ± 18.37 | <0.0001 |
|
|